627 results on '"BARONE A. C"'
Search Results
52. Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin
53. A role for triglyceride lipase brummer in the regulation of sex differences in Drosophila fat storage and breakdown
54. Selective CETP Inhibition and PPARα Agonism Increase HDL Cholesterol and Reduce LDL Cholesterol in Human ApoB100/Human CETP Transgenic Mice
55. The Synergistic Effect of Time of Exposure, Distance and No Use of Personal Protective Equipment in the Determination of SARS-CoV-2 Infection: Results of a Contact Tracing Follow-Up Study in Healthcare Workers
56. Cytokines in Brain Ischemia—The Role of TNFα
57. Pharmacologic Interventions for Stroke: Looking Beyond the Thrombolysis Time Window Into the Penumbra With Biomarkers, Not a Stopwatch
58. Selective CETP inhibition and PPAR agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice
59. Gene Discovery Underlying Stroke
60. Magnetoelastic sensor for real-time monitoring of elastic deformation and fracture alarm
61. SB 234551 selective ETA receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection
62. Biocompatibility studies of fluorescent diamond particles-(NV)∼800nm (part V): in vitro kinetics and in vivo localization in rat liver following long-term exposure
63. Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke
64. Concomitant cortical expression of TNF-α and IL-1β mRNAs follows early response gene expression in transient focal ischemia
65. Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, and particle distribution and excretion studies (part IV)
66. Glucosylceramide Synthase Activity and Ceramide Levels Are Modulated During Cerebral Ischemia After Ischemic Preconditioning
67. Inhibition of Factor IX(a) Is Protective in a Rat Model of Thromboembolic Stroke
68. The Antithrombotic Efficacy of Lotrafiban (SB 214857) in Canine Models of Acute Coronary Thrombosis
69. Stroke Genomics: Approaches to Identify, Validate, and Understand Ischemic Stroke Gene Expression
70. The Novel β-Blocker, Carvedilol, Provides Neuroprotection in Transient Focal Stroke
71. Detection of Tumor Necrosis Factor-α mRNA Induction in Ischemic Brain Tolerance by Means of Real-Time Polymerase Chain Reaction
72. Inflammatory Cytokines and Stroke: Emerging New Strategies for Stroke Therapeutics
73. Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
74. Matrix Remodeling after Stroke: De Novo Expression of Matrix Proteins and Integrin Receptors
75. Double triage to identify poorly annotated genes in maize: The missing link in community curation
76. Long-term biocompatibility of fluorescent diamonds-(NV)-Z~800 nm in rats: survival, morbidity, histopathology, and particle distribution and excretion studies (part IV)
77. Use of Suppression Subtractive Hybridization Strategy for Discovery of Increased Tissue Inhibitor of Matrix Metalloproteinase-1 Gene Expression in Brain Ischemic Tolerance
78. Ischemic Preconditioning and Brain Tolerance: Temporal Histological and Functional Outcomes, Protein Synthesis Requirement, and Interleukin-1 Receptor Antagonist and Early Gene Expression
79. Prolonged Expression of Interferon-Inducible Protein-10 in Ischemic Cortex After Permanent Occlusion of the Middle Cerebral Artery in Rat
80. Osteopontin and its Integrin Receptor alphav beta3 Are Upregulated During Formation of the Glial Scar After Focal Stroke
81. Matrix Metalloproteinase Expression Increases After Cerebral Focal Ischemia in Rats: Inhibition of Matrix Metalloproteinase-9 Reduces Infarct Size
82. Subtractive Cloning Identifies Tissue Inhibitor of Matrix Metalloproteinase-1 (TIMP-1) Increased Gene Expression Following Focal Stroke
83. Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the rat
84. The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury
85. The Effects of SB 206284A, A Novel Neuronal Calcium-Channel Antagonist, in Models of Cerebral Ischemia
86. Interleukin-1 Receptor and Receptor Antagonist Gene Expression After Focal Stroke in Rats
87. Demonstration of Increased Endothelial-Leukocyte Adhesion Molecule-1 mRNA Expression in Rat Ischemic Cortex
88. Editorial Comment
89. Monocyte Chemoattractant Protein-1 Messenger RNA Expression in Rat Ischemic Cortex
90. Expression of Interleukin-6, c-Fos, and zif268 mRNAs in Rat Ischemic Cortex
91. Pilot study on biocompatibility of fluorescent nanodiamond-(NV)-Z~800 particles in rats: safety, pharmacokinetics, and bio-distribution (part III)
92. Tumor Necrosis Factor-α Expression in Ischemic Neurons
93. Endothelin Levels Increase in Rat Focal and Global Ischemia
94. Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisation
95. Receptor binding and biological activity of the dermorphin analog Tyr- d-Arg 2-Phe-Sar (TAPS)
96. SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia
97. Interleukin-1β mRNA Expression in Ischemic Rat Cortex
98. Mouse Strain Differences in Susceptibility to Cerebral Ischemia are Related to Cerebral Vascular Anatomy
99. Reperfusion Increases Neutrophils and Leukotriene B4 Receptor Binding in Rat Focal Ischemia
100. Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.